My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
June 2012
Your Colleagues
Check Out “My IDSA” for Latest Member News

Find the latest membership news on “My IDSA” on the IDSA website, including new IDSA members; updates on Ardis Dee Hoven, MD, Thomas M. File, Jr., MD, FIDSA, and Edward J.Septimus, MD, FIDSA; and a remembrance of Emanuel Wolinsky, MD.

Are you a member on the move? Do you know someone who is? Contact Stephanie Cox at scox@idsociety.org so that we can announce it to our membership.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
ACIP Adjusts Influenza Vaccine Dosing for Young Children
CDC Updates Recommendations for Carbapenem-Resistant Enterobacteriaceae
New Guideline Pocketcards: Rhinosinusitis and Diabetic Foot Infection
Clinical Practice Management
IDSA Weighs In on CMS Inpatient Proposed Rule
Global ID
“Cured” HIV Patient, Researchers Discuss AIDS Fight
WHO: Pregnant Women with HIV Should Have Access to Optimal Drug
TB Treatment Trial Raises Hopes
Policy and Advocacy
IDSA Supports Universal Vaccination Through State Mandates
IDSA Leads Support for Increased BARDA Funding
IDSA Supports Age-Based HCV Screening Guidelines
Society Comments on Federal Action Plan to Prevent HAIs
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
Clinical Microbiology Learning Tool Available Online
How to Manage Information Overload
Top Stories
Congress Passes Antibiotic Incentives Legislation
Supreme Court Upholds Health Care Reform Law
EIN Update: CDC Encourages Submission of Suspected C. gattii Isolates
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.